Melatonin Orion

Melatonin, the active ingredient in Melatonin Orion, is a melatonin receptor agonist presented as an oral dosage form for oral use. It treats insomnia, sleep onset disorder and jet lag in adults.

GNH USA supplies Melatonin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Orion is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle.

- Insomnia: helps reduce time to fall asleep and improve sleep continuity. - Sleep onset disorder: facilitates earlier sleep initiation in individuals with delayed sleep phase. - Jet lag: assists in adjusting circadian rhythm after rapid time‑zone travel.

Melatonin Orion may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness: feeling of sleepiness during daytime. - Headache: mild to moderate headache. - Dizziness: sensation of light‑headedness. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or vivid dreams. - Hormonal effects: alterations in menstrual cycle (rare).

Before using Melatonin Orion, consider the following precautions to ensure safe and effective use.

- Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Age: use caution in children and adolescents; dosing should be individualized. - Concomitant medications: review all current drugs with a clinician to avoid interactions. - Underlying conditions: inform the prescriber of any liver, kidney or psychiatric disorders. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Melatonin Orion can interact with other substances that affect its metabolism or pharmacodynamic profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): potential alteration of drug levels.

Moderate Interactions (Monitor Closely): - Sedatives or CNS depressants: additive drowsiness. - Oral contraceptives: possible reduction in melatonin effectiveness. - Antidepressants (e.g., SSRIs): may enhance serotonergic effects. - Caffeine: may diminish sleep‑promoting action.